- Filed
- Aug 4, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Jul 27, 2021 | 38.69M sh |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $76.18M |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $144.6M |
| Current Liabilities | Q2 2021 · Jun 30, 2021 | $220.83M |
| Current Liabilities | Q2 2021 · Dec 31, 2020 | $245.58M |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $867.75M |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $899.77M |
| Current Assets | Q2 2021 · Jun 30, 2021 | $314.63M |
| Current Assets | Q2 2021 · Dec 31, 2020 | $374.87M |
| Total Assets | Q2 2021 · Jun 30, 2021 | $931.64M |
| Total Assets | Q2 2021 · Dec 31, 2020 | $950.75M |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 38.33M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 38.42M sh |
| Capex | Q2 2021 · Jun 30, 2020 | $15.74M |
| Operating Cash Flow | Q2 2021 · Jun 30, 2020 | $80.06M |
| Stockholders Equity | Q2 2021 · Jun 30, 2020 | $20.85M |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | −$16M |
| Stockholders Equity | Q2 2021 · Dec 31, 2019 | $9.5M |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | $0.81 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | $0.40 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | $0.82 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | $0.41 |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $33.62M |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $65.39M |
| Net Income | Q2 2021 · Jun 30, 2020 | $31.05M |
| Net Income | Q2 2021 · Jun 30, 2020 | $15.31M |
| Net Income | Q2 2021 · Mar 31, 2020 | −$15.75M |
| Operating Income | Q2 2021 · Jun 30, 2020 | $38.86M |
| Operating Income | Q2 2021 · Jun 30, 2020 | $29.69M |
| Revenue | Q2 2021 · Jun 30, 2020 | $233.43M |
| Revenue | Q2 2021 · Jun 30, 2020 | $467.17M |